Altrafin AG’s GE Aerospace GE Stock Holding History

Altrafin AG’s Portfolio GE Stock Details GE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.86M	Sell	10,324 -1,933	-16%	-$605K	1.51%	21
2026 Q1	$3.48M	Buy	+12,257	New	+$3.85M	1.2%	24
2022 Q1	–	Sell	-12,841	Closed	-$756K	–	89
2021 Q4	$756K	Buy	+12,841	New	+$807K	0.27%	68

Other funds holding GE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCI Fund Management London, United Kingdom $52.8B AUM 12.71% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Altrafin AG's GE Position: Q2 2026 in Review

Altrafin AG reduced its GE Aerospace (GE) stake by 16% in Q2 2026, selling an estimated $605K and leaving 10,324 shares worth $3.86M. The position accounts for 1.51% of the portfolio, ranked #21.

Altrafin AG first reported a position in GE in Q4 2021 and has held it in 3 quarters since. 3,427 funds tracked by Wall St. Rank hold GE as of Q2 2026.

Altrafin AG held 10,324 shares of GE Aerospace worth $3.86M as of Q2 2026.
Altrafin AG sold 1,933 GE Aerospace shares in Q2 2026, an estimated $605K.
GE Aerospace made up 1.51% of Altrafin AG's portfolio in Q2 2026, its #21 holding.
Altrafin AG first reported a position in GE Aerospace in Q4 2021 and has held it in 3 quarters since.
3,427 funds tracked by Wall St. Rank held GE Aerospace as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.